Medically reviewed by Jamin Brahmbhatt, MD The treatment of metastatic castration-resistant prostate cancer (mCRPC) involves ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

A new technology is offering hope to men with low to intermediate-risk prostate cancer by providing a less invasive treatment ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Erleada reduced the risk of death by more than 20% compared with other treatments in metastatic castration-sensitive prostate ...

Francis Medical in Maple Grove has raised about $160 million — and wants to roughly double this — as it plans for an initial ...

Lenny Santoro credits NIH research with saving his life longer than doctors expected. Duke Health's Dr. Daniel George warns ...

“Building on decades of research into the genetic markers of prostate cancer, our study shows that the theory does work in ...

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...